David Juurlink
Born1968 (age 5556)
NationalityCanadian
Alma materDalhousie University[1]
OccupationPhysician

David Juurlink (/ˈjʊərlɪŋk/ YURE-link;[2] born New Glasgow, Nova Scotia) is a Canadian pharmacologist and internist. He is head of the Clinical Pharmacology and Toxicology division at Sunnybrook Health Sciences Centre in Toronto, Ontario, as well as a medical toxicologist at the Ontario Poison Centre and a scientist at the Institute for Clinical Evaluative Sciences. He is known for researching adverse effects caused by drug interactions, with some of this research funded by a New Investigator Award from the Canadian Institutes for Health Research.[3] He has been very critical of his fellow physicians' regular prescribing of dangerous opioids like Tramadol[4] and fentanyl.[5][6] In June 2017, he published a letter analyzing citations to "Addiction Rare in Patients Treated with Narcotics", a 1980 letter in The New England Journal of Medicine that has often been cited to claim that opioids like OxyContin are rarely addictive.[7]

References

  1. "David Juurlink". Retrieved 26 October 2020.
  2. "Meet the Expert Video Series featuring ICES senior scientist Dr. David Juurlink". YouTube. June 2, 2015. Retrieved 29 November 2022.
  3. "We are Sunnybrook". The Globe and Mail. 7 May 2011. Retrieved 24 June 2017.
  4. Kirkup, Kristy (26 February 2017). "Health Canada's position on opioid Tramadol is indefensible: doctor". The Globe and Mail. Retrieved 24 June 2017.
  5. Kirkey, Sharon (7 April 2016). "Doctors' reckless prescribing of fentanyl largely to blame for deadly overdoses: expert". National Post. Retrieved 24 June 2017.
  6. "Dr. David Juurlink says colleagues must accept blame for fentanyl ODs". CBC News. 24 August 2015. Retrieved 24 June 2017.
  7. "Opioid crisis: The letter that started it all". BBC News. 3 June 2017. Retrieved 24 June 2017.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.